Centaurus Financial, Inc.
- SEC CIK
- 0000891943
- Latest filing
- Aug 17, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Centaurus Financial, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −752−100.0% | Sold out | Holders |
| Q1 2023 | 752 | $151.0K | <0.1% | +11+1.5% | Added | Holders |
| Q4 2022 | 741 | $176.0K | <0.1% | +18+2.5% | Added | Holders |
| Q3 2022 | 723 | $145.0K | <0.1% | +23+3.3% | Added | Holders |
| Q2 2022 | 700 | $102.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 700 | $114.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 700 | $119.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 700 | $132.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 700 | $119.0K | <0.1% | +700 | New | Holders |